The neuroprotective potential of arginine-rich peptides for the acute treatment of traumatic brain injury

Expert Rev Neurother. 2016;16(4):361-3. doi: 10.1586/14737175.2016.1150180. Epub 2016 Feb 18.

Authors

Li Shan Chiu^{1

2}, Ryan S Anderton^{1

2

3}, Neville W Knuckey^{1

2

4}, Bruno P Meloni^{1

2

4}

Affiliations

¹ a Western Australian Neuroscience Research Institute , Nedlands , Australia.
² b Centre for Neuromuscular and Neurological Disorders , The University of Western Australia , Nedlands , Australia.
³ c School of Heath Sciences , The University Notre Dame Australia , Fremantle , Western Australia , Australia.
⁴ d Department of Neurosurgery , Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands , Western Australia , Australia.

PMID: 26840929
DOI: 10.1586/14737175.2016.1150180

No abstract available

Publication types

Editorial

MeSH terms

Animals
Arginine*
Brain Injuries, Traumatic / drug therapy*
Humans
Nerve Growth Factors
Neuroprotective Agents / therapeutic use*
Peptides / chemistry
Peptides / therapeutic use*

Substances

MANF protein, human
Nerve Growth Factors
Neuroprotective Agents
Peptides
Arginine